N Boeckx
Overview
Explore the profile of N Boeckx including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Feller N, van der Velden V, Brooimans R, Boeckx N, Preijers F, Kelder A, et al.
Blood Cancer J
. 2013 Aug;
3:e129.
PMID: 23912609
Flow-cytometric detection of minimal residual disease (MRD) has proven in several single-institute studies to have an independent prognostic impact. We studied whether this relatively complex approach could be performed in...
12.
Dekking E, van der Velden V, Varro R, Wai H, Bottcher S, Kneba M, et al.
Leukemia
. 2012 Sep;
26(9):1976-85.
PMID: 22948489
The PML-RARA fusion protein is found in approximately 97% of patients with acute promyelocytic leukemia (APL). APL can be associated with life-threatening bleeding complications when undiagnosed and not treated expeditiously....
13.
Dekking E, van der Velden V, Bottcher S, Bruggemann M, Sonneveld E, Koning-Goedheer A, et al.
Best Pract Res Clin Haematol
. 2010 Dec;
23(3):333-45.
PMID: 21123134
Nowadays, the presence of specific genetic aberrations is progressively used for classification and treatment stratification, because acute leukemias with the same oncogenetic aberration generally form a clinically and diagnostically homogenous...
14.
Weerkamp F, Dekking E, Ng Y, van der Velden V, Wai H, Bottcher S, et al.
Leukemia
. 2009 Apr;
23(6):1106-17.
PMID: 19387467
BCR-ABL fusion proteins show increased signaling through their ABL tyrosine kinase domain, which can be blocked by specific inhibitors, thereby providing effective treatment. This makes detection of BCR-ABL aberrations of...
15.
Put N, Meeus P, Chatelain B, Rack K, Boeckx N, Nollet F, et al.
Leukemia
. 2009 Mar;
23(6):1201-4.
PMID: 19295547
No abstract available.
16.
Sprangers B, Van Wijmeersch B, Luyckx A, Sagaert X, De Somer L, Rutgeerts O, et al.
Leukemia
. 2008 Nov;
23(2):340-9.
PMID: 18987665
The role of graft-versus-malignancy reactivity in the effects of allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusion (DLI) for myelodysplastic syndromes is as yet not well established. Clinical data...
17.
Boeckx N, Renard M, Uyttebroeck A
Br J Haematol
. 2007 Jan;
137(1):2.
PMID: 17214738
No abstract available.
18.
Cloos J, Goemans B, Hess C, van Oostveen J, Waisfisz Q, Corthals S, et al.
Leukemia
. 2006 Apr;
20(7):1217-20.
PMID: 16642044
In acute myeloid leukemia (AML), activating mutations in the fms-like tyrosine kinase 3 (FLT3) gene predict poor prognosis. We determined FLT3 internal tandem duplications (FLT3/ITD) and D835 point mutations in...
19.
Boeckx N, Roover J, van der Velden V, Maertens J, Uyttebroeck A, Vandenberghe P, et al.
Leukemia
. 2005 Sep;
19(11):1988-90.
PMID: 16193088
No abstract available.
20.
Boeckx N, Jansen M, Haskovec C, Vandenberghe P, van der Velden V, van Dongen J
Leukemia
. 2005 Apr;
19(7):1292-5.
PMID: 15843824
No abstract available.